Site specific chemotherapy in periodontal management: an exciting new direction.
Bader
H I
HI
Harvard School of Medicine.
D000287:Administration, Topical; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002710:Chlorhexidine / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use; D004338:Drug Combinations; D016503:Drug Delivery Systems; D006801:Humans; D010510:Periodontal Diseases / Q000188:drug therapy*; D012459:Salicylates / Q000008:administration & dosage / Q000627:therapeutic use; D013729:Terpenes / Q000008:administration & dosage / Q000627:therapeutic use; D014002:Tin Fluorides / Q000008:administration & dosage / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D012459:Salicylates; D013729:Terpenes; D014002:Tin Fluorides; C057473:Listerine; C010882:chlorhexidine gluconate; D002710:Chlorhexidine